Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs.

Biochemical pharmacology

Schleiff MA, Crosby S, Blue M, Schleiff BM, Boysen G, Miller GP.
PMID: 34748821
Biochem Pharmacol. 2021 Dec;194:114824. doi: 10.1016/j.bcp.2021.114824. Epub 2021 Nov 05.

Diphenylamine NSAIDs are taken frequently for chronic pain conditions, yet their use may potentiate hepatotoxicity risks through poorly characterized metabolic mechanisms. Our previous work revealed that seven marketed or withdrawn diphenylamine NSAIDs undergo bioactivation into quinone-species metabolites, whose reaction...

Cite
Schleiff MA, Crosby S, Blue M, et al. CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs. Biochem Pharmacol. 2021;194:114824doi: 10.1016/j.bcp.2021.114824.
Schleiff, M. A., Crosby, S., Blue, M., Schleiff, B. M., Boysen, G., & Miller, G. P. (2021). CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs. Biochemical pharmacology, 194114824. https://doi.org/10.1016/j.bcp.2021.114824
Schleiff, Mary Alexandra, et al. "CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs." Biochemical pharmacology vol. 194 (2021): 114824. doi: https://doi.org/10.1016/j.bcp.2021.114824
Schleiff MA, Crosby S, Blue M, Schleiff BM, Boysen G, Miller GP. CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs. Biochem Pharmacol. 2021 Dec;194:114824. doi: 10.1016/j.bcp.2021.114824. Epub 2021 Nov 05. PMID: 34748821.
Copy Download .nbib Format: NLM
Metabolic Forest: Predicting the Diverse Structures of Drug Metabolites.

Journal of chemical information and modeling

Hughes TB, Dang NL, Kumar A, Flynn NR, Swamidass SJ.
PMID: 32881497
J Chem Inf Model. 2020 Oct 26;60(10):4702-4716. doi: 10.1021/acs.jcim.0c00360. Epub 2020 Sep 16.

Adverse drug metabolism often severely impacts patient morbidity and mortality. Unfortunately, drug metabolism experimental assays are costly, inefficient, and slow. Instead, computational modeling could rapidly flag potentially toxic molecules across thousands of candidates in the early stages of drug...

Cite
Hughes TB, Dang NL, Kumar A, et al. Metabolic Forest: Predicting the Diverse Structures of Drug Metabolites. J Chem Inf Model. 2020;60(10):4702-4716doi: 10.1021/acs.jcim.0c00360.
Hughes, T. B., Dang, N. L., Kumar, A., Flynn, N. R., & Swamidass, S. J. (2020). Metabolic Forest: Predicting the Diverse Structures of Drug Metabolites. Journal of chemical information and modeling, 60(10), 4702-4716. https://doi.org/10.1021/acs.jcim.0c00360
Hughes, Tyler B, et al. "Metabolic Forest: Predicting the Diverse Structures of Drug Metabolites." Journal of chemical information and modeling vol. 60,10 (2020): 4702-4716. doi: https://doi.org/10.1021/acs.jcim.0c00360
Hughes TB, Dang NL, Kumar A, Flynn NR, Swamidass SJ. Metabolic Forest: Predicting the Diverse Structures of Drug Metabolites. J Chem Inf Model. 2020 Oct 26;60(10):4702-4716. doi: 10.1021/acs.jcim.0c00360. Epub 2020 Sep 16. PMID: 32881497; PMCID: PMC8716321.
Copy Download .nbib Format: NLM
XenoNet: Inference and Likelihood of Intermediate Metabolite Formation.

Journal of chemical information and modeling

Flynn NR, Dang NL, Ward MD, Swamidass SJ.
PMID: 32525671
J Chem Inf Model. 2020 Jul 27;60(7):3431-3449. doi: 10.1021/acs.jcim.0c00361. Epub 2020 Jun 29.

Drug metabolism is a common cause of adverse drug reactions. Drug molecules can be metabolized into reactive metabolites, which can conjugate to biomolecules, like protein and DNA, in a process termed bioactivation. To mitigate adverse reactions caused by bioactivation,...

Cite
Flynn NR, Dang NL, Ward MD, et al. XenoNet: Inference and Likelihood of Intermediate Metabolite Formation. J Chem Inf Model. 2020;60(7):3431-3449doi: 10.1021/acs.jcim.0c00361.
Flynn, N. R., Dang, N. L., Ward, M. D., & Swamidass, S. J. (2020). XenoNet: Inference and Likelihood of Intermediate Metabolite Formation. Journal of chemical information and modeling, 60(7), 3431-3449. https://doi.org/10.1021/acs.jcim.0c00361
Flynn, Noah R, et al. "XenoNet: Inference and Likelihood of Intermediate Metabolite Formation." Journal of chemical information and modeling vol. 60,7 (2020): 3431-3449. doi: https://doi.org/10.1021/acs.jcim.0c00361
Flynn NR, Dang NL, Ward MD, Swamidass SJ. XenoNet: Inference and Likelihood of Intermediate Metabolite Formation. J Chem Inf Model. 2020 Jul 27;60(7):3431-3449. doi: 10.1021/acs.jcim.0c00361. Epub 2020 Jun 29. PMID: 32525671.
Copy Download .nbib Format: NLM
XenoNet: Inference and Likelihood of Intermediate Metabolite Formation.

Journal of chemical information and modeling

Flynn NR, Dang NL, Ward MD, Swamidass SJ.
PMID: 32525671
J Chem Inf Model. 2020 Jul 27;60(7):3431-3449. doi: 10.1021/acs.jcim.0c00361. Epub 2020 Jun 29.

Drug metabolism is a common cause of adverse drug reactions. Drug molecules can be metabolized into reactive metabolites, which can conjugate to biomolecules, like protein and DNA, in a process termed bioactivation. To mitigate adverse reactions caused by bioactivation,...

Cite
Flynn NR, Dang NL, Ward MD, et al. XenoNet: Inference and Likelihood of Intermediate Metabolite Formation. J Chem Inf Model. 2020;60(7):3431-3449doi: 10.1021/acs.jcim.0c00361.
Flynn, N. R., Dang, N. L., Ward, M. D., & Swamidass, S. J. (2020). XenoNet: Inference and Likelihood of Intermediate Metabolite Formation. Journal of chemical information and modeling, 60(7), 3431-3449. https://doi.org/10.1021/acs.jcim.0c00361
Flynn, Noah R, et al. "XenoNet: Inference and Likelihood of Intermediate Metabolite Formation." Journal of chemical information and modeling vol. 60,7 (2020): 3431-3449. doi: https://doi.org/10.1021/acs.jcim.0c00361
Flynn NR, Dang NL, Ward MD, Swamidass SJ. XenoNet: Inference and Likelihood of Intermediate Metabolite Formation. J Chem Inf Model. 2020 Jul 27;60(7):3431-3449. doi: 10.1021/acs.jcim.0c00361. Epub 2020 Jun 29. PMID: 32525671; PMCID: PMC8716322.
Copy Download .nbib Format: NLM
Modeling Reactivity to Biological Macromolecules with a Deep Multitask Network.

ACS central science

Hughes TB, Dang NL, Miller GP, Swamidass SJ.
PMID: 27610414
ACS Cent Sci. 2016 Aug 24;2(8):529-37. doi: 10.1021/acscentsci.6b00162. Epub 2016 Jul 29.

Most small-molecule drug candidates fail before entering the market, frequently because of unexpected toxicity. Often, toxicity is detected only late in drug development, because many types of toxicities, especially idiosyncratic adverse drug reactions (IADRs), are particularly hard to predict...

Cite
Hughes TB, Dang NL, Miller GP, et al. Modeling Reactivity to Biological Macromolecules with a Deep Multitask Network. ACS Cent Sci. 2016;2(8):529-37doi: 10.1021/acscentsci.6b00162.
Hughes, T. B., Dang, N. L., Miller, G. P., & Swamidass, S. J. (2016). Modeling Reactivity to Biological Macromolecules with a Deep Multitask Network. ACS central science, 2(8), 529-37. https://doi.org/10.1021/acscentsci.6b00162
Hughes, Tyler B, et al. "Modeling Reactivity to Biological Macromolecules with a Deep Multitask Network." ACS central science vol. 2,8 (2016): 529-37. doi: https://doi.org/10.1021/acscentsci.6b00162
Hughes TB, Dang NL, Miller GP, Swamidass SJ. Modeling Reactivity to Biological Macromolecules with a Deep Multitask Network. ACS Cent Sci. 2016 Aug 24;2(8):529-37. doi: 10.1021/acscentsci.6b00162. Epub 2016 Jul 29. PMID: 27610414; PMCID: PMC4999971.
Copy Download .nbib Format: NLM
CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs.

Biochemical pharmacology

Schleiff MA, Crosby S, Blue M, Schleiff BM, Boysen G, Miller GP.
PMID: 34748821
Biochem Pharmacol. 2021 Dec;194:114824. doi: 10.1016/j.bcp.2021.114824. Epub 2021 Nov 05.

Diphenylamine NSAIDs are taken frequently for chronic pain conditions, yet their use may potentiate hepatotoxicity risks through poorly characterized metabolic mechanisms. Our previous work revealed that seven marketed or withdrawn diphenylamine NSAIDs undergo bioactivation into quinone-species metabolites, whose reaction...

Cite
Schleiff MA, Crosby S, Blue M, et al. CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs. Biochem Pharmacol. 2021;194:114824doi: 10.1016/j.bcp.2021.114824.
Schleiff, M. A., Crosby, S., Blue, M., Schleiff, B. M., Boysen, G., & Miller, G. P. (2021). CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs. Biochemical pharmacology, 194114824. https://doi.org/10.1016/j.bcp.2021.114824
Schleiff, Mary Alexandra, et al. "CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs." Biochemical pharmacology vol. 194 (2021): 114824. doi: https://doi.org/10.1016/j.bcp.2021.114824
Schleiff MA, Crosby S, Blue M, Schleiff BM, Boysen G, Miller GP. CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs. Biochem Pharmacol. 2021 Dec;194:114824. doi: 10.1016/j.bcp.2021.114824. Epub 2021 Nov 05. PMID: 34748821; PMCID: PMC8710044.
Copy Download .nbib Format: NLM
Learning a Local-Variable Model of Aromatic and Conjugated Systems.

ACS central science

Matlock MK, Dang NL, Swamidass SJ.
PMID: 29392176
ACS Cent Sci. 2018 Jan 24;4(1):52-62. doi: 10.1021/acscentsci.7b00405. Epub 2018 Jan 03.

A collection of new approaches to building and training neural networks, collectively referred to as deep learning, are attracting attention in theoretical chemistry. Several groups aim to replace computationally expensive

Cite
Matlock MK, Dang NL, Swamidass SJ. Learning a Local-Variable Model of Aromatic and Conjugated Systems. ACS Cent Sci. 2018;4(1):52-62doi: 10.1021/acscentsci.7b00405.
Matlock, M. K., Dang, N. L., & Swamidass, S. J. (2018). Learning a Local-Variable Model of Aromatic and Conjugated Systems. ACS central science, 4(1), 52-62. https://doi.org/10.1021/acscentsci.7b00405
Matlock, Matthew K, et al. "Learning a Local-Variable Model of Aromatic and Conjugated Systems." ACS central science vol. 4,1 (2018): 52-62. doi: https://doi.org/10.1021/acscentsci.7b00405
Matlock MK, Dang NL, Swamidass SJ. Learning a Local-Variable Model of Aromatic and Conjugated Systems. ACS Cent Sci. 2018 Jan 24;4(1):52-62. doi: 10.1021/acscentsci.7b00405. Epub 2018 Jan 03. PMID: 29392176; PMCID: PMC5785769.
Copy Download .nbib Format: NLM
CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs.

Biochemical pharmacology

Schleiff MA, Crosby S, Blue M, Schleiff BM, Boysen G, Miller GP.
PMID: 34748821
Biochem Pharmacol. 2021 Dec;194:114824. doi: 10.1016/j.bcp.2021.114824. Epub 2021 Nov 05.

Diphenylamine NSAIDs are taken frequently for chronic pain conditions, yet their use may potentiate hepatotoxicity risks through poorly characterized metabolic mechanisms. Our previous work revealed that seven marketed or withdrawn diphenylamine NSAIDs undergo bioactivation into quinone-species metabolites, whose reaction...

Cite
Schleiff MA, Crosby S, Blue M, et al. CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs. Biochem Pharmacol. 2021;194:114824doi: 10.1016/j.bcp.2021.114824.
Schleiff, M. A., Crosby, S., Blue, M., Schleiff, B. M., Boysen, G., & Miller, G. P. (2021). CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs. Biochemical pharmacology, 194114824. https://doi.org/10.1016/j.bcp.2021.114824
Schleiff, Mary Alexandra, et al. "CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs." Biochemical pharmacology vol. 194 (2021): 114824. doi: https://doi.org/10.1016/j.bcp.2021.114824
Schleiff MA, Crosby S, Blue M, Schleiff BM, Boysen G, Miller GP. CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs. Biochem Pharmacol. 2021 Dec;194:114824. doi: 10.1016/j.bcp.2021.114824. Epub 2021 Nov 05. PMID: 34748821.
Copy Download .nbib Format: NLM
XenoNet: Inference and Likelihood of Intermediate Metabolite Formation.

Journal of chemical information and modeling

Flynn NR, Dang NL, Ward MD, Swamidass SJ.
PMID: 32525671
J Chem Inf Model. 2020 Jul 27;60(7):3431-3449. doi: 10.1021/acs.jcim.0c00361. Epub 2020 Jun 29.

Drug metabolism is a common cause of adverse drug reactions. Drug molecules can be metabolized into reactive metabolites, which can conjugate to biomolecules, like protein and DNA, in a process termed bioactivation. To mitigate adverse reactions caused by bioactivation,...

Cite
Flynn NR, Dang NL, Ward MD, et al. XenoNet: Inference and Likelihood of Intermediate Metabolite Formation. J Chem Inf Model. 2020;60(7):3431-3449doi: 10.1021/acs.jcim.0c00361.
Flynn, N. R., Dang, N. L., Ward, M. D., & Swamidass, S. J. (2020). XenoNet: Inference and Likelihood of Intermediate Metabolite Formation. Journal of chemical information and modeling, 60(7), 3431-3449. https://doi.org/10.1021/acs.jcim.0c00361
Flynn, Noah R, et al. "XenoNet: Inference and Likelihood of Intermediate Metabolite Formation." Journal of chemical information and modeling vol. 60,7 (2020): 3431-3449. doi: https://doi.org/10.1021/acs.jcim.0c00361
Flynn NR, Dang NL, Ward MD, Swamidass SJ. XenoNet: Inference and Likelihood of Intermediate Metabolite Formation. J Chem Inf Model. 2020 Jul 27;60(7):3431-3449. doi: 10.1021/acs.jcim.0c00361. Epub 2020 Jun 29. PMID: 32525671.
Copy Download .nbib Format: NLM
CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs.

Biochemical pharmacology

Schleiff MA, Crosby S, Blue M, Schleiff BM, Boysen G, Miller GP.
PMID: 34748821
Biochem Pharmacol. 2021 Dec;194:114824. doi: 10.1016/j.bcp.2021.114824. Epub 2021 Nov 05.

Diphenylamine NSAIDs are taken frequently for chronic pain conditions, yet their use may potentiate hepatotoxicity risks through poorly characterized metabolic mechanisms. Our previous work revealed that seven marketed or withdrawn diphenylamine NSAIDs undergo bioactivation into quinone-species metabolites, whose reaction...

Cite
Schleiff MA, Crosby S, Blue M, et al. CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs. Biochem Pharmacol. 2021;194:114824doi: 10.1016/j.bcp.2021.114824.
Schleiff, M. A., Crosby, S., Blue, M., Schleiff, B. M., Boysen, G., & Miller, G. P. (2021). CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs. Biochemical pharmacology, 194114824. https://doi.org/10.1016/j.bcp.2021.114824
Schleiff, Mary Alexandra, et al. "CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs." Biochemical pharmacology vol. 194 (2021): 114824. doi: https://doi.org/10.1016/j.bcp.2021.114824
Schleiff MA, Crosby S, Blue M, Schleiff BM, Boysen G, Miller GP. CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs. Biochem Pharmacol. 2021 Dec;194:114824. doi: 10.1016/j.bcp.2021.114824. Epub 2021 Nov 05. PMID: 34748821.
Copy Download .nbib Format: NLM
Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics.

Drug metabolism and disposition: the biological fate of chemicals

Schleiff MA, Flynn NR, Payakachat S, Schleiff BM, Pinson AO, Province DW, Swamidass SJ, Boysen G, Miller GP.
PMID: 33239334
Drug Metab Dispos. 2021 Feb;49(2):133-141. doi: 10.1124/dmd.120.000254. Epub 2020 Nov 25.

Meclofenamate is a nonsteroidal anti-inflammatory drug used in the treatment of mild-to-moderate pain yet poses a rare risk of hepatotoxicity through an unknown mechanism. Nonsteroidal anti-inflammatory drug (NSAID) bioactivation is a common molecular initiating event for hepatotoxicity. Thus, we...

Cite
Schleiff MA, Flynn NR, Payakachat S, et al. Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics. Drug Metab Dispos. 2020;49(2):133-141doi: 10.1124/dmd.120.000254.
Schleiff, M. A., Flynn, N. R., Payakachat, S., Schleiff, B. M., Pinson, A. O., Province, D. W., Swamidass, S. J., Boysen, G., & Miller, G. P. (2021). Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics. Drug metabolism and disposition: the biological fate of chemicals, 49(2), 133-141. https://doi.org/10.1124/dmd.120.000254
Schleiff, Mary Alexandra, et al. "Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics." Drug metabolism and disposition: the biological fate of chemicals vol. 49,2 (2021): 133-141. doi: https://doi.org/10.1124/dmd.120.000254
Schleiff MA, Flynn NR, Payakachat S, Schleiff BM, Pinson AO, Province DW, Swamidass SJ, Boysen G, Miller GP. Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics. Drug Metab Dispos. 2021 Feb;49(2):133-141. doi: 10.1124/dmd.120.000254. Epub 2020 Nov 25. PMID: 33239334; PMCID: PMC7841419.
Copy Download .nbib Format: NLM
CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs.

Biochemical pharmacology

Schleiff MA, Crosby S, Blue M, Schleiff BM, Boysen G, Miller GP.
PMID: 34748821
Biochem Pharmacol. 2021 Dec;194:114824. doi: 10.1016/j.bcp.2021.114824. Epub 2021 Nov 05.

Diphenylamine NSAIDs are taken frequently for chronic pain conditions, yet their use may potentiate hepatotoxicity risks through poorly characterized metabolic mechanisms. Our previous work revealed that seven marketed or withdrawn diphenylamine NSAIDs undergo bioactivation into quinone-species metabolites, whose reaction...

Cite
Schleiff MA, Crosby S, Blue M, et al. CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs. Biochem Pharmacol. 2021;194:114824doi: 10.1016/j.bcp.2021.114824.
Schleiff, M. A., Crosby, S., Blue, M., Schleiff, B. M., Boysen, G., & Miller, G. P. (2021). CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs. Biochemical pharmacology, 194114824. https://doi.org/10.1016/j.bcp.2021.114824
Schleiff, Mary Alexandra, et al. "CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs." Biochemical pharmacology vol. 194 (2021): 114824. doi: https://doi.org/10.1016/j.bcp.2021.114824
Schleiff MA, Crosby S, Blue M, Schleiff BM, Boysen G, Miller GP. CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs. Biochem Pharmacol. 2021 Dec;194:114824. doi: 10.1016/j.bcp.2021.114824. Epub 2021 Nov 05. PMID: 34748821; PMCID: PMC8710044.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries